Based on these findings, we speculate that the activation of the Wnt/β-catenin and JAK-2/STAT-3 signaling pathways by SRPK1 promotes the proliferation, migration, and invasion of gliomas (Figure 7G). This evidence concerns the gene SRPK1 and central nervous system cancer.